Cargando…
Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials
Smoking drug interaction studies represent a common approach for the clinical investigation of CYP1A2 induction. Despite this important role, they remain an “orphan topic” in the existing regulatory framework of drug interaction studies, and important methodological aspects remain unaddressed. The U...
Autores principales: | Hermann, Robert, Rostami‐Hodjegan, Amin, Zhao, Ping, Ragueneau‐Majlessi, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175975/ https://www.ncbi.nlm.nih.gov/pubmed/36752279 http://dx.doi.org/10.1111/cts.13494 |
Ejemplares similares
-
Tobacco Substitutes: Harm Reduction or Smokescreen?
Publicado: (2007) -
Clearing the Smokescreen: The Current Evidence on Cannabis Use
por: Temple, Elizabeth Clare
Publicado: (2015) -
Smokescreen: a targeted genotyping array for addiction research
por: Baurley, James W., et al.
Publicado: (2016) -
Analysis of factors influencing infrared extinction area of explosive smokescreen
por: He, Haihao, et al.
Publicado: (2022) -
In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
por: Yu, Jingjing, et al.
Publicado: (2020)